methylphenidate prolonged release tablet - 12 hrs acting / Generic mfg.  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

20 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
methylphenidate prolonged release tablet - 12 hrs acting / Generic mfg.
NCT00181792: Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity Disorder (ADHD) Youth Treated With Concerta

Completed
N/A
70
US
Massachusetts General Hospital
ADHD, Smoking
08/09
08/09
NCT00598182: Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study

Completed
N/A
64
RoW
National Taiwan University Hospital
Attention Deficit Disorder With Hyperactivity
 
09/09
NCT01130467: Event-related Potentials in Management of Children With Attention-deficit/Hyperactivity Disorder

Unknown status
N/A
150
RoW
methylphenidate, Ritalin, Concerta, Atomoxetine, Straterra, behavioral modification
Far Eastern Memorial Hospital, Academia Sinica, Taiwan, National Taiwan University Hospital
Attention Deficit Disorders With Hyperactivity, Attention Deficit Disorder, Hyperkinetic Syndrome
12/11
 
NCT01533493: Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study

Completed
N/A
33
US
Placebo, Memantine Hydrochloride, Namenda, OROS-Methylphenidate, OROS-MPH, Concerta
Massachusetts General Hospital, The American Professional Society of ADHD and Related Disorders (APSARD)
Attention Deficit Hyperactivity Disorder (ADHD), Executive Function Deficits (EFD)
07/13
08/13
NCT02730572: Concerta (Methylphenidate) -To-Generic Switch Study

Completed
N/A
1464
NA
Concerta, Methylphenidate, Concerta AG formulation, Concerta EG formulation
Janssen Research & Development, LLC
Attention Deficit Disorder With Hyperactivity
10/16
10/16
NCT02699528: The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder

Unknown status
N/A
50
RoW
methylphenidate, Ritalin, Concerta
Meir Medical Center
Attention Deficit Hyperactivity Disorder, Enuresis
04/17
05/17
NCT02392169: Neuroendocrine Substrates, Candidate Genes and Endophenotypes in ADHD

Unknown status
N/A
300
RoW
Methylphenidate, Retalin, concerta
Chang Gung Memorial Hospital
Attention Deficit Hyperactivity Disorder
07/17
07/17
AAOFDIYWA, NCT03358277: Aripiprazole Added on for DMDD in Youths With ADHD

Completed
N/A
58
NA
MPH + APZ, MPH (Ritalin, Concerta), APZ (Abilify)
Tri-Service General Hospital, Ministry of Science and Technology, Taiwan
Disruptive Mood Dysregulation Disorder
08/17
08/17
NCT02210728: Efficacy of Cognitive Behavioral Therapy in Treatment of Adults With Attention Deficit Hyperactivity Disorder

Unknown status
N/A
200
Canada
methylphenidate or amphetamine product, Ritalin, Concerta, Biphentin, Dexedrine, Adderall XR, Vyvanse, Cognitive behavioral therapy
Lily Hechtman
Attention Deficit Hyperactivity Disorder
10/18
10/18
NCT02788851: The Effectiveness of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Unknown status
N/A
70
Canada
Methylphenidate compounds and /or Amphetamine compounds and/or Strattera or Guanfacine, Ritalin, Concerta, Biphentin, Dexedrine, Adderall XR, Vyvanse, Strattera, Guanfacine, Intuniv, Aerobic Exercise
McGill University Health Centre/Research Institute of the McGill University Health Centre
Attention Deficit Hyperactivity Disorder (ADHD)
12/18
12/18
NCT02142140: Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)

Unknown status
N/A
326
Canada
Academic and Organization skills, Parent Training, Social Skills Training, Long-acting stimulant, Biphentin, Strattera, Concerta, Ritalin, Vyvanse, Adderall, Dexedrine
McGill University Health Centre/Research Institute of the McGill University Health Centre, Canadian Institutes of Health Research (CIHR)
Attention Deficit Hyperactivity Disorder (ADHD)
02/19
02/19
NCT04113551: A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan

Completed
N/A
17418
US
MPH (Concerta), MPH (Ritalin), Atomoxetine (ATO), Guanfacine (GFC)
Janssen Research & Development, LLC
Attention Deficit Disorder With Hyperactivity
01/20
01/20
NCT02430896: Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD

Unknown status
N/A
600
RoW
Methylphenidate (MPH), Metadate CD®, Concerta®, Medikinet Retard®, Atomoxetine, Straterra®
Asan Medical Center
Attention Deficit Disorder With Hyperactivity
06/20
12/20
ADAPT, NCT02136147: ADHD Medication and Predictors of Treatment Outcome

Completed
N/A
632
Europe
methylphenidate medication, N06BA04, Concerta, Ritalin, Equasym, Medikinet, atomoxetine medication, N06BA09, Strattera, lisdexamphetamine medication, N06BA12, Elvanse, guanfacine medication, C02AC02, Intuniv
Karolinska Institutet
Attention Deficit Disorder With Hyperactivity (ADHD)
07/21
06/22
NCT04577417: Stimulant Medication Effects on Auditory Sensitivity in Teens With ADHD

Completed
N/A
70
US
ADHD stimulants, for example, amphetamine, dexmethylphenidate, dextroamphetamine, methylphenidate, Adderall, Focalin, Ritalin, Vyvanse, Concerta
Nemours Children's Clinic
Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder, Attention Deficit Disorder With Hyperactivity
06/22
06/22
NCT04647500: Effects of Methylphenidate on Brain and Cognition in 22q11 Deletion Syndrome

Completed
N/A
45
Europe
Concerta
University of Geneva, Switzerland
22q11.2 Deletion Syndrome
09/22
09/22
NCT05229627: Multimodal Magnetic Resonance Imaging Study on the Neural Mechanisms of Remission in Children With ADHD

Enrolling by invitation
N/A
250
NA
MPH, Concerta, ATX, Strattera
Peking University Sixth Hospital, Hangzhou Normal University
ADHD
12/22
12/23
CHEC2023-296, NCT06369714: Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children.

Recruiting
N/A
200
RoW
Concerta, Methylphenidate Hydrochloride Extended-Release Tablets, Digital therapeutics
Lei Lei, MD
Attention Deficit Disorder With Hyperactivity, Executive Function Disorder
02/25
02/25
ChiCTR2300070680: Study on predictors of the effect of Concerta on cognitive information processing in children with attention deficit hyperactivity disorder.

Not yet recruiting
N/A
150
 
none
People’s Hospital of Guangxi Zhuang Autonomous Region; People’s Hospital of Guangxi Zhuang Autonomous Region, Not
Attention deficit hyperactivity disorder
 
 
NCT03425669: Acoustic and Vestibular Noise as Possible Non-pharmacological Treatment of ADHD in School Children

Recruiting
N/A
70
Europe
Stochastic Vestibular Stimulation, Auditory white noise stimulation, Sham stimulation, Active medication, Concerta, Ritalin, Methylphenidate, Equasym or Medikinet
Lund University
ADHD
05/24
05/27

Download Options